Duavive: new combo for menopausal vasomotor symptomsIncludes selective estrogen receptor modulator to reduce risk of estrogen-related endometrial hyperplasia MedsCheck Diabetes: study examines first 3.5 years in OntarioAbout half of diabetes patients received an initial assessment, but follow-up assessment rate was low Weight-loss drug helps stave off diabetes Daily injections of liraglutide effective over three years, but not without side-effects Fiasp: new fast-acting mealtime insulin aspart formulation More rapid onset of action and earlier peak effect than original insulin aspart New Canadian guidelines for prevention and treatment of hypertension in children Address health behaviour management, when to start drug therapy, choice of therapy, and therapy goals. Subclinical hypothyroidism treatment a bust in seniors Levothyroxine does not improve symptoms in randomized trial Inappropriate drugs common in nursing home residents with dementia Ontario study shows medications of ‘questionable benefit’ common in last week of life What’s new in the 2017 Canadian hypertension guidelines? Annual update reviews the diagnosis, risk assessment, prevention and treatment of hypertension in Canadian adults Letrozole off-label use to manage infertility expected to rise Will offer an alternative to clomiphene citrate, which is being discontinued. PCSK9 inhibitor cuts cardiovascular event rate in major trial But injectable cholesterol-lowering biologic shows no mortality benefit over two years First Previous 96 97 98 99 100 Next Last
